Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?

Gastroenterology. 2016 Aug;151(2):373. doi: 10.1053/j.gastro.2015.11.055. Epub 2016 Jul 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bias
  • Hepacivirus
  • Hepatitis C*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Liver Cirrhosis

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors